. . . . . . . . . . . . . . . . . . . . . . . "TextLocation" . "Review" . "act(p(HGNC:ADRB2)) => complex(p(HGNC:ADRB2),p(SFAM:\"PDE4 Family\"),p(SFAM:\"ARRB Family\"))" . "Approximately 2000 hand curated statements drawn from 57 PubMeds." . "Copyright (c) 2011-2012, Selventa. All Rights Reserved." . "BEL Framework Small Corpus Document" . "Creative Commons Attribution-Non-Commercial-ShareAlike 3.0 Unported License" . . "20131211" . "support@belframework.org" . "Selventa" . "Originally identified by high-throughput screening of small molecules against C-Raf\nkinase, sorafenib was found to be a potent competitive inhibitor of ATP binding\nin the catalytic domains of C-Raf, wild-type B-Raf, and V599EB-Raf mutant." . . . . . "2014-07-03T14:31:15.858+02:00"^^ . . .